SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-159586
Filing Date
2016-11-29
Accepted
2016-11-29 16:04:03
Documents
3
Period of Report
2016-11-29
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-22258_18k.htm 8-K 35911
2 EX-99.1 a16-22258_1ex99d1.htm EX-99.1 12665
3 GRAPHIC g222581mmi001.jpg GRAPHIC 4723
  Complete submission text file 0001104659-16-159586.txt   56668
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 162022790
SIC: 2835 In Vitro & In Vivo Diagnostic Substances